Medicine shortage reports database
The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.
Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.
How to search
The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.
To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.
You can also download an extract of all shortages and discontinuations.
To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.
Further information
Information about medicine shortages is available at the Medicine Shortages hub
Subscribe to Medicine Shortages updates
You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.
This service does not support Internet Explorer 7 and below.
Search Results
Browse CRITICAL shortages and discontinuations
Click here to display ALL medicine shortages and discontinuations
AUST R: 14332
Expected supply: 31 May 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 24-05-2022
phenoxybenzamine hydrochloride
AUST R: 12980
Expected supply: 30 Jun 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient..
Updated: 20-06-2022
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 25mg capsule bottle
AUST R: 42975
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 17-06-2022
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 50mg capsule bottle
AUST R: 42976
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 26-07-2022
AUST R: 263913
Expected supply: 30 Sep 2022
Availability: Unavailable
Management action: Stock is available from the sponsor to supply via the Special Access Scheme
Updated: 22-06-2022
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Expected supply: 31 Dec 2024
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 07-03-2022
CIPLA BLEOMYCIN 15K bleomycin sulfate 15000 IU powder for injection vial
AUST R: 220440
Expected supply: 30 Jun 2021
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 16-06-2022
ETHYOL Amifostine (as trihydrate) 500mg powder for injection vial
AUST R: 63789
Expected supply: 31 Jul 2023
Availability: Unavailable
Management action: Alternative unapproved products available under the Special Access Scheme.
Updated: 27-07-2022
DBL SULFAMETHOXAZOLE 400 mg AND TRIMETHOPRIM 80 mg CONCENTRATE INJECTION BP 5mL injection ampoule
AUST R: 16293
Expected supply: 24 Feb 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 11-07-2022
AUST R: 101670
Expected supply: 31 Dec 2022
Availability: Unavailable
Management action: Alternative unapproved products available under the Special Access Scheme (SAS). For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme
Updated: 16-12-2021
tetracosactide (tetracosactrin)
SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule
AUST R: 11060
Expected supply: 30 Nov 2022
Availability: Unavailable
Management action: Alternative unapproved products available under the Special Access Scheme (SAS). For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme
Updated: 16-06-2022
AUST R: 16339
Expected supply: Unknown
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 30-03-2022
procaine benzylpenicillin (procaine penicillin)
CILICAINE SYRINGE 1.5 procaine benzylpenicillin (procaine penicillin) 1.5g injection syringe
AUST R: 288818
Expected supply: 31 Aug 2022
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment.
Updated: 27-07-2022
AUST R: 13705
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative unapproved products may be available under the Special Access Scheme (SAS). For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme
Updated: 16-06-2022
HYDRALAZINE LINK hydralazine hydrochloride 20 mg/1 mL solution for injection vial
AUST R: 272644
Expected supply: 31 Jan 2023
Availability: Unavailable
Management action: Alternative generic products may be available
Updated: 16-06-2022
AUST R: 235933
Expected supply: 31 Dec 2022
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 14-06-2022
AUST R: 238265
Expected supply: Unknown
Availability: Available
Management action: Alternative generic products are available.
Updated: 14-06-2022
CARBOSORB XS activated charcoal 50 g/250 mL and sorbitol 70.75 g/250 mL suspension bottle
AUST R: 307429
Expected supply: 01 Nov 2022
Availability: Unavailable
Management action: Possible therapeutic alternative available.
CARBOSORB X activated charcoal 50 g/250 mL suspension bottle ARTG ID: 106470
Updated: 14-06-2022
PREGNYL gonadotrophin - chorionic human 1500IU powder for injection vial with diluent vial
AUST R: 273873
Expected supply: Unknown
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
The sponsor of this s19A product, Medsurge can be contacted on: 1300 788 261 for details on supply.
Updated: 11-10-2021
PREGNYL gonadotrophin - chorionic human 5000IU powder for injection vial with diluent vial
AUST R: 273874
Expected supply: Unknown
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
The sponsor of this s19A product, Organon Pharma can be contacted on: 1800 023 135 for details on supply.
Updated: 11-10-2021
dexamethasone sodium phosphate
DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4mg/1mL (as sodium) injection ampoule
AUST R: 16374
Expected supply: Unknown
Availability: Unavailable
Management action: An alternate presentation of the same strength is available.
Updated: 06-04-2022
DBL CIPROFLOXACIN 400 mg/200 mL injection for intravenous infusion bag
AUST R: 123042
Expected supply: 13 May 2022
Availability: Available
Updated: 18-05-2022
adrenaline (epinephrine) acid tartrate
lidocaine (lignocaine) hydrochloride
AUST R: 12015
Expected supply: 15 Sep 2022
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 10-02-2022
adrenaline (epinephrine) acid tartrate
lidocaine (lignocaine) hydrochloride
AUST R: 12021
Expected supply: 15 Sep 2022
Availability: Unavailable
Management action: Unregistered products have been approved for supply under Section 19A to Medsurge Healthcare Pty Ltd (1300 788 261) and Pro Pharmaceuticals Group Pty Ltd (1300 077 674).
Updated: 31-01-2022
adrenaline (epinephrine) acid tartrate
lidocaine (lignocaine) hydrochloride
XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12008
Expected supply: 15 Sep 2022
Availability: Unavailable
Management action: An unregistered product in other strength has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 14-06-2022
OPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial
AUST R: 231867
Expected supply: 24 May 2022
Availability: Available
Updated: 24-05-2022
AUST R: 48231
Expected supply: 31 Aug 2022
Availability: Limited Availability
Management action: Alternative generic products are available.
Updated: 16-06-2022
DBL LEUCOVORIN CALCIUM folinic acid 50 mg/5 mL (as calcium folinate) injection USP vial (NF)
AUST R: 42148
Expected supply: 19 Aug 2022
Availability: Limited Availability
Updated: 03-08-2022
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack
AUST R: 60673
Expected supply: 31 Oct 2022
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Pro Pharmaceuticals Group can be contacted on 1300 077 674 for details on supply.
Updated: 18-05-2022
AUST R: 81930
Expected supply: 30 Apr 2023
Availability: Unavailable
Updated: 03-05-2022
AUST R: 81931
Expected supply: 30 Apr 2023
Availability: Unavailable
Updated: 03-05-2022
FUNNEL WEB SPIDER ANTIVENOM (RABBIT) 125U powder for injection vial
AUST R: 31847
Expected supply: 31 Jan 2023
Availability: Available
Management action: The sponsor is closely controlling the supply.
Updated: 02-07-2022
dexamethasone sodium phosphate
AUST R: 163200
Expected supply: 27 Oct 2022
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Alphapharm Pty Ltd can be contacted on 1800 274 276 for details on supply
Updated: 12-07-2022
VANCOMYCIN JUNO vancomycin (as hydrochloride) 1 g powder for injection vial
AUST R: 330502
Expected supply: 25 Jul 2022
Availability: Available
Updated: 26-07-2022
BENPEN benzylpenicillin (as sodium) 3g powder for injection vial
AUST R: 10327
Expected supply: 22 Jul 2022
Availability: Available
Updated: 22-07-2022
Updated: 20-05-2022
DBL CIPROFLOXACIN 200 mg/100 mL injection for intravenous infusion bag
AUST R: 123041
Expected supply: 13 May 2022
Availability: Available
Updated: 07-06-2022
METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe
AUST R: 75013
Expected supply: 31 Mar 2023
Availability: Limited Availability
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of certain batches of Metalyse by 12 months, information on batch numbers and extended expiry dates is available in the web statement.
Unregistered alternative products have been approved for supply under Section 19A. For information on supply, contact the approval holder, Pro Pharmaceuticals Group Pty Ltd on 1300 077 674.
Updated: 13-07-2022
DBL HEPARIN SODIUM (porcine mucous) 5000IU/0.2mL injection BP ampoule
AUST R: 16349
Expected supply: 09 May 2022
Availability: Available
Updated: 11-05-2022
AUST R: 61885
Expected supply: 30 Aug 2022
Availability: Available
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 11-07-2022
LARGACTIL chlorpromazine hydrochloride 100mg tablet blister pack
AUST R: 51619
Expected supply: 11 May 2022
Availability: Available
Updated: 11-05-2022
BENPEN benzylpenicillin (as sodium) 1.2g powder for injection vial
AUST R: 10326
Expected supply: 15 Aug 2022
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 20-07-2022
Pfizer (Australia) DAUNORUBICIN (as hydrochloride) 20mg/10mL injection vial
AUST R: 12723
Expected supply: 30 Jun 2022
Availability: Available
Updated: 04-07-2022
benzathine benzylpenicillin tetrahydrate
AUST R: 147169
Expected supply: 25 Jul 2022
Availability: Available
Updated: 26-07-2022
benzathine benzylpenicillin tetrahydrate
AUST R: 293456
Expected supply: 19 Jul 2022
Availability: Available
Updated: 20-07-2022
AUST R: 94175
Expected supply: 15 Jan 2023
Availability: Available
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 05-08-2022
CORDARONE X INTRAVENOUS amiodarone hydrochloride 150mg/3mL injection ampoule
AUST R: 15360
Expected supply: 11 May 2022
Availability: Available
Updated: 11-05-2022
DBL ACETYLCYSTEINE injection concentrate acetylcysteine 2 g/ 10 mL injection ampoule
AUST R: 121503
Expected supply: 12 Aug 2022
Availability: Emergency Supply Only
Management action: Alternative generic product is available. An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Orspec Pharma - Phone (02) 43394239 Email: sas@orspecpharma.com
Updated: 05-08-2022
adrenaline (epinephrine) acid tartrate
ADRENALINE-LINK 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP ampoule
AUST R: 119194
Expected supply: 31 Jan 2023
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 16-06-2022
DBL DESFERRIOXAMINE MESYLATE FOR INJECTION BP 500mg powder for injection vial
AUST R: 53942
Expected supply: 25 Jul 2022
Availability: Available
Updated: 26-07-2022
AUST R: 49945
Expected supply: 04 Nov 2022
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 16-06-2022
AUST R: 49422
Expected supply: 31 Dec 2022
Availability: Unavailable
Management action: A TGA webstatement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
Unregistered products have been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient or 'contrast'.
Updated: 15-06-2022
AUST R: 47996
Expected supply: 31 Dec 2022
Availability: Unavailable
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
An unregistered product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply.
Updated: 09-06-2022
AUST R: 47997
Expected supply: 31 Dec 2022
Availability: Unavailable
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
An unregistered product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply.
Updated: 09-06-2022
AUST R: 47998
Expected supply: 31 Dec 2022
Availability: Unavailable
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
An unregistered product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply.
Updated: 09-06-2022
naloxone hydrochloride dihydrate
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
AUST R: 309381
Expected supply: 15 Nov 2022
Availability: Emergency Supply Only
Management action: Sponsor is closely monitoring supply.
An unregistered product has been approved for supply under Section 19A. The approval holder, Mundipharma Pty Ltd can be contacted on 1800 188 009 for details on supply.
Updated: 05-08-2022
DBL VANCOMYCIN vancomycin (as hydrochloride) 500mg powder for injection vial
AUST R: 62603
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An alternative brand is available.
Updated: 15-06-2022
YERVOY ipilimumab (rch) 200mg in 40mL (5mg/mL) concentrate solution for IV infusion vial
AUST R: 174322
Expected supply: 09 Jun 2022
Availability: Available
Updated: 10-06-2022
AUST R: 12511
Expected supply: 12 Aug 2022
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 27-07-2022
adrenaline (epinephrine) acid tartrate
AUST R: 210672
Expected supply: 24 Jun 2022
Availability: Available
Updated: 29-06-2022
MIVACRON mivacurium 10mg/5mL (as chloride) injection ampoule
AUST R: 42972
Expected supply: 15 Aug 2022
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment.
Updated: 11-07-2022
DBL LEUCOVORIN CALCIUM folinic acid 15 mg/2mL (as calcium folinate) injection ampoule
AUST R: 16351
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternate strengths available
Updated: 08-06-2022
AUST R: 67398
Expected supply: 15 Oct 2022
Availability: Available
Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.
Updated: 15-06-2022
AUST R: 46943
Expected supply: 03 Sep 2022
Availability: Limited Availability
Management action: The sponsor is working to expedite the next shipment. An alternative brand is also available.
Updated: 06-07-2022
METALYSE tenecteplase (rch) 40mg powder for injection vial plus prefilled syringe
AUST R: 75012
Expected supply: 31 Mar 2023
Availability: Limited Availability
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of certain batches of Metalyse by 12 months, information on batch numbers and extended expiry dates is available in the web statement.
Updated: 13-07-2022
VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial
AUST R: 267013
Expected supply: 31 Dec 2022
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 11-07-2022
AUST R: 93680
Expected supply: 01 Aug 2022
Availability: Available
Updated: 01-08-2022
AUST R: 11302
Expected supply: 12 Jul 2022
Availability: Available
Updated: 22-07-2022
dexamethasone sodium phosphate
AUST R: 163199
Expected supply: 31 Oct 2022
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Alphapharm Pty Ltd can be contacted on 1800 274 276 for details on supply
Updated: 12-07-2022
MESTINON TIMESPAN pyridostigmine bromide 180mg tablet bottle
AUST R: 13749
Expected supply: 17 Oct 2022
Availability: Limited Availability
Management action: Sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 05-08-2022
AUST R: 101240
Expected supply: 10 Aug 2022
Availability: Limited Availability
Management action: Alternative generic products are available.
Updated: 22-07-2022
Influenza virus haemagglutinin
AUST R: 242512
Expected supply: 01 Apr 2023
Availability: Limited Availability
Management action: Seasonal depletion of stock.
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 22-07-2022
AUST R: 13747
Expected supply: 09 Sep 2022
Availability: Limited Availability
Management action: Supply of an alternative product is under consideration.
Updated: 26-07-2022
{{headingLabels[selectedTab]}}
Sort by: Updated date | Active ingredient | Trade name | Therapeutic class
URL: http://apps.tga.gov.au/prod/MSI/search/